ProQR (PRQR) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
ProQR Therapeutics N.V. has entered into an underwriting agreement to sell 18 million ordinary shares with the option for underwriters to purchase an additional 2.7 million shares. This public offering is facilitated by representatives from Evercore Group L.L.C. and Cantor Fitzgerald & Co., signaling a significant move in the market for investors interested in the biotech sector.
For further insights into PRQR stock, check out TipRanks’ Stock Analysis page.
